Insider Trading activities of Pieris Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pieris Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pieris Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Pieris Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is PIRS. The reporting company's CIK number is 1583648.
The total value of stock buying since 2005 is $3,146,966.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $7,950.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pieris Pharmaceuticals, Inc. (PIRS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 75,000 $361,550 0 $0 0 $0
2017-04 0 $0 0 $0 5,000 $7,950
2016-06 21,000 $35,416 0 $0 0 $0
2015-07 1,000,000 $2,750,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pieris Pharmaceuticals, Inc. insiders (PIRS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-17 Reine Allan (See Remarks) Buy 20,000 4.89 97,800
2017-08-17 Geraghty James A (Director) Buy 10,000 4.82 48,200
2017-08-16 Reine Allan (See Remarks) Buy 45,000 4.79 215,550
2017-04-21 Kiritsy Christopher P (Director) Option Ex 5,000 1.59 7,950
2016-06-14 Matis Louis (SVP, Chief Development Officer) Buy 7,915 1.71 13,534
2016-06-13 Matis Louis (SVP, Chief Development Officer) Buy 2,085 1.68 3,502
2016-06-13 Yoder Stephen S. (President and CEO) Buy 6,000 1.68 10,080
2016-06-13 Deptula-hicks Darlene M (SVP, Chief Financial Officer) Buy 5,000 1.66 8,300
2015-07-06 Khuong Chau Quang (Director) Buy 500,000 2.75 1,375,000
2015-07-06 Isaly Samuel D (Director) Buy 500,000 2.75 1,375,000

Insider trading activities including stock purchases, stock sales, and option exercises of PIRS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pieris Pharmaceuticals, Inc. (symbol PIRS, CIK number 1583648) see the Securities and Exchange Commission (SEC) website.